ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 711

Prevalence and Risk Factors of Depressive Disorders in Chinese Patients with Systemic Lupus Erythematosus (SLE)

Chi Chiu Mok1, Yan Tung Lilian Lo2, Chi Wai Cheng2 and Kam Shan Poon2, 1Medicine, Tuen Mun Hospital, Hong Kong, Hong Kong, 2Psychiatry, Castle Peak Hospital, Hong Kong, Hong Kong

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Lupus and neuropsychiatric disorders

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Systemic Lupus Erythematosus – Clinical Aspects and Treatment Poster I: Biomarkers and Outcomes

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Depression is common in SLE but most previous studies utilized self-rated scales for evaluation. Formal diagnosis of depression was not established by psychiatric interviews. This study was conducted to determine the prevalence of depressive disorders, severity of depressive symptoms and the associated risk factors in Chinese patients with SLE.

Methods:

Adult patients who fulfilled ≥4 ACR criteria for SLE were randomly recruited from the rheumatology out-patient clinics and hospital admissions in a 6-month period. Psychiatric disorders were diagnosed through a direct interview by a designated psychiatrist using the Chinese-bilingual Structural Clinical Interview for DSM-IV Axis I disorders, patient research version (CB-SCID-I/P). The severity of depressive symptoms was assessed by the Hamilton Depressive Rating Scale (HAM-D). Patients were asked to complete the Beck Depression Inventory (BDI), Medical Outcomes Study Social Support Survey (MOS-SSS-C) and the WHO Quality of Life Measure-Abbreviated Version. SLE disease activity (SLEDAI), organ damage (SLICC/SDI) and socio-demographic were collected and correlated with the presence of psychiatric disorders. Logistic regression was used to study the risk factors for psychiatric disorders in SLE.

Results:

175 SLE patients were studied (95% women, age 39.2±12.4 years, SLE duration 10.3±6.7 years). Twenty-seven (15.4%) and 37 (21.1%) patients were diagnosed as having a current depressive (52% major depressive disorder, 22% dysthymia) and anxiety (35% generalized anxiety, 14% panic, 14% phobia, 8% adjustment disorder) disorder, respectively. Patients with depressive disorders, as compared to those without any psychiatric disorders, had higher SLE activity (p=0.03), were more likely to have a history of psychiatric diagnosis (p<0.001) and receive financial assistance from the Government (p=0.04). Independent factors associated with a current depressive disorder were SLEDAI score (1.13[1.02-1.24] per point; p=0.02), perceived poor social support (p=0.03) and a past history of psychiatric disorders (p=0.003). On the other hand, being separated/divorced (β=0.19; p=0.02), higher SLEDAI score (β=0.16; p=0.02), shorter SLE duration (β= -0.18; p=0.02) and a history of psychiatric disorders (β=0.18; p=0.01) were independently associated with higher HAM-D scores, which reflected the severity of depression. Depressive disorders and severity of depression were associated with poorer quality of life. ROC analysis showed a cut-off of 14 points of the self-rated BDI had a sensitivity of 89% and a specificity of 83% for providing good psychometric property for differentiating a current depressive disorder from those without.

Conclusion:

Depressive disorder is prevalent in Chinese patients with SLE. Independent risk factors include more active disease, perceived poor social support and a past history of psychiatric disorders. Patients with more active SLE, shorter disease duration, a past history of psychiatric disorders and being separated are associated with more serious depressive symptoms. The self-rated BDI provides a good screening tool for identifying depressive disorders in SLE patients.


Disclosure: C. C. Mok, None; Y. T. L. Lo, None; C. W. Cheng, None; K. S. Poon, None.

To cite this abstract in AMA style:

Mok CC, Lo YTL, Cheng CW, Poon KS. Prevalence and Risk Factors of Depressive Disorders in Chinese Patients with Systemic Lupus Erythematosus (SLE) [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/prevalence-and-risk-factors-of-depressive-disorders-in-chinese-patients-with-systemic-lupus-erythematosus-sle/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/prevalence-and-risk-factors-of-depressive-disorders-in-chinese-patients-with-systemic-lupus-erythematosus-sle/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology